BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Araujo RLC, Herman P, Riechelmann RP. Recurrence-free survival as a putative surrogate for overall survival in phase III trials of curative-intent treatment of colorectal liver metastases: Systematic review. World J Clin Oncol 2017; 8(3): 266-272 [PMID: 28638797 DOI: 10.5306/wjco.v8.i3.266]
URL: https://www.wjgnet.com/2218-4333/full/v8/i3/266.htm
Number Citing Articles
1
Nicholas A. Bosma, Alysha R. Keehn, Richard Lee-Ying, Safiya Karim, Anthony R. MacLean, Darren R. Brenner. Efficacy of perioperative chemotherapy in resected colorectal liver metastasis: A systematic review and meta-analysisEuropean Journal of Surgical Oncology 2021; 47(12): 3113 doi: 10.1016/j.ejso.2021.07.024
2
Eliza W. Beal, Shruthi Srinivas, Chengli Shen, Alex Kim, Fabian M. Johnston, Jonathan Greer, Daniel E. Abbott, Courtney Pokrzywa, Mustafa Raoof, Travis E. Grotz, Jennifer L. Leiting, Keith Fournier, Sean Dineen, Benjamin Powers, Jula Veerapong, Anai Kothari, Ugwuji Maduekew, Shishir Maithel, Gregory C. Wilson, Sameer H. Patel, Laura Lambert, Sherif Abdel-Misih, Jordan M. Cloyd. Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC CollaborativeAnnals of Surgical Oncology 2023; 30(3): 1840 doi: 10.1245/s10434-022-12753-0
3
Ravi Rajaram, Qing Huang, Richard Z. Li, Urmila Chandran, Yuxin Zhang, Tony B. Amos, George W.J. Wright, Nicole C. Ferko, Iftekhar Kalsekar. Recurrence-Free Survival in Patients With Surgically Resected Non-Small Cell Lung CancerCHEST 2024; 165(5): 1260 doi: 10.1016/j.chest.2023.11.042
4
Morganna Freeman, Keith A. Betts, Shan Jiang, Ella X. Du, Komal Gupte-Singh, Yichen Lu, Sumati Rao, Alexander N. Shoushtari. Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab as Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial DataAdvances in Therapy 2019; 36(10): 2783 doi: 10.1007/s12325-019-01060-y
5
Yan Zhang, Deyou Zheng. PseudogenesMethods in Molecular Biology 2021; 2324: 307 doi: 10.1007/978-1-0716-1503-4_19
6
Eiichi Nakao, Michitaka Honda, Noriyuki Uesugi, Mitsumasa Osakabe, Ayaka Sato, Yukitoshi Todate, Mizunori Yaegashi, Yoshinao Takano, Akira Sasaki, Koji Kono, Tamotsu Sugai. Evaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapyJournal of Surgical Oncology 2024;  doi: 10.1002/jso.27662
7
Raphael L. C. Araujo, Jean Michel Milani, Daniela Pezzutti Armentano, Raphael Brandão Moreira, Gustavo S. F. Pinto, Luís Antônio de Castro, Fabiano R. Lucchesi. Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapyJournal of Surgical Oncology 2020; 121(5): 848 doi: 10.1002/jso.25784
8
Nicholas A. Bosma, Winson Y. Cheung, Maclean Thiessen, Caroline Speers, Daniel J. Renouf, Derek Tilley, Patricia A. Tang, Chad G. Ball, Elijah Dixon, Richard M. Lee-Ying. Real-World Outcomes of Oxaliplatin-Based Chemotherapy on R0 Resected Colonic Liver MetastasisClinical Colorectal Cancer 2021; 20(3): e201 doi: 10.1016/j.clcc.2021.04.004
9
Brett L Ecker, Jasme Lee, Lily V Saadat, Thomas Aparicio, Florian E Buisman, Vinod P Balachandran, Jeffrey A Drebin, Kiyoshi Hasegawa, William R Jarnagin, Nancy E Kemeny, T Peter Kingham, Bas Groot Koerkamp, Norihiro Kokudo, Yutaka Matsuyama, Guillaume Portier, Leonard B Saltz, Kevin C Soares, Alice C Wei, Mithat Gonen, Michael I D'Angelica. Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysisThe Lancet Oncology 2022; 23(10): 1332 doi: 10.1016/S1470-2045(22)00506-X